Ferring, Fuji Pharma Tie Up for Cervical Ripening Agent Propess

November 5, 2021
Ferring Pharmaceuticals and Fuji Pharma said on November 4 that they have agreed to collaborate in Japan for the Swiss drug maker’s Propess 10 mg vaginal delivery system (dinoprostone), an agent for cervical ripening. Fuji Pharma will be responsible for...read more